Arsenic trioxide (Trisenox®) in patients with relapsed or refractory multiple myeloma (MM):: Final report of a phase II clinical study.

被引：0
|
作者：
Hussein, MA
Mason, J
Saleh, MN
Rifkin, RM
Ravandi, F
机构：
[1] Cleveland Clin Canc Ctr, Multiple Myeloma Res Program, Cleveland, OH USA
[2] Scripps Clin, San Diego, CA USA
[3] Georgia Canc Specialists, Atlanta, GA USA
[4] Rocky Mt Canc Ctr, Denver, CO USA
[5] Univ Illinois, Chicago, IL USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5138
引用
收藏
页码：393B / 393B
页数：1
相关论文
共 50 条
  • [41] Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma
    Farag, Sherif S.
    Zhang, Shuhong
    Jansak, Buffy S.
    Wang, Xiaojing
    Kraut, Eric
    Chan, Kenneth
    Dancey, Janet E.
    Grever, Michael R.
    LEUKEMIA RESEARCH, 2009, 33 (11) : 1475 - 1480
  • [42] Lenalidomide, bortezomib, and dexamethasone (Rev/Vel/Dex) in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary results of a phase II study
    Richardson, Paul
    Jagannath, Sundaf
    Raje, Noopur
    Jakubowiak, Andrzej
    Lonial, Sagar
    Ghobrial, Irene
    Schlossman, Robert
    Mazumder, Amitabha
    Munshi, Nikhil
    Colson, Kathleen
    McKenney, Mary
    Farrell, Melissa
    Lunde, Laura
    Giove, Lawrence
    Kaster, Sarah
    Mitsiades, Constantine
    Hideshima, Teru
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth
    BLOOD, 2007, 110 (11) : 797A - 797A
  • [43] A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients
    Rousselot, P
    Larghero, J
    Arnulf, B
    Poupon, J
    Royer, B
    Tibi, A
    Madelaine-Chambrin, J
    Cimerman, P
    Chevret, S
    Hermine, O
    Dombret, H
    Brouet, JC
    Fermand, JP
    LEUKEMIA, 2004, 18 (09) : 1518 - 1521
  • [44] A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients
    P Rousselot
    J Larghero
    B Arnulf
    J Poupon
    B Royer
    A Tibi
    I Madelaine-Chambrin
    P Cimerman
    S Chevret
    O Hermine
    H Dombret
    J Claude Brouet
    J Paul Fermand
    Leukemia, 2004, 18 : 1518 - 1521
  • [45] Phase II study of thalidomide with dexamethasone for relapsed/refractory multiple myeloma
    Kinoshita, T
    Ohno, T
    Yuge, M
    Hiraga, J
    Matsushita, T
    Ando, S
    Naoe, T
    ANNALS OF ONCOLOGY, 2005, 16 : 206 - 206
  • [46] A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients
    Bringhen, Sara
    Magarotto, Valeria
    Liberati, Anna Marina
    Belotti, Angelo
    Larocca, Alessandra
    Gilestro, Milena
    Bonello, Francesca
    Gaidano, Gianluca
    Bertazzoni, Paola
    Stocchi, Raffaella
    Ribolla, Rossella
    Di Sano, Chiara
    Patriarca, Francesca
    Passera, Roberto
    De Paoli, Lorenzo
    Oliva, Stefania
    Cafro, Anna Maria
    Sonneveld, Pieter
    Palumbo, Antonio
    Boccadoro, Mario
    BLOOD, 2016, 128 (22)
  • [47] A Phase 3 Study of Carfilzomib and Dexamethasone (Kd) in Patients With Relapsed and Refractory Multiple Myeloma (MM) in China
    Du, Juan
    Fang, Baijun
    Li, Jian
    Jin, Jie
    Wang, Shunqing
    Zou, Dehui
    Cai, Zhen
    Wang, Hongxiang
    Hu, Jianda
    Li, Wei
    Fu, Chengcheng
    Shao, Zonghong
    Xia, Zhongjun
    Liu, Peng
    Niu, Ting
    Tang, En-Tzu
    Kimball, Amy
    Hou, Jian
    Chen, Wenming
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E267 - E268
  • [48] Arsenic trioxide in patients with myelodysplastic syndromes (MDS): Preliminary results of a phase II clinical study.
    List, AF
    Schiller, GJ
    Mason, J
    Douer, D
    Ellison, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 561S - 561S
  • [49] Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study
    Berenson, James R.
    Boccia, Ralph
    Siegel, David
    Bozdech, Marek
    Bessudo, Alberto
    Stadtmauer, Edward
    Pomeroy, J. Talisman
    Steis, Ronald
    Flam, Marshall
    Lutzky, Jose
    Jilani, Syed
    Volk, Joseph
    Wong, Siu-Fun
    Moss, Robert
    Patel, Ravi
    Ferretti, Delina
    Russell, Kit
    Louie, Robert
    Yeh, Howard S.
    Swift, Regina A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) : 174 - 183
  • [50] Lenalidomide, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma (MM): Encouraging outcomes and tolerability in a phase II study
    Anderson, K. C.
    Jagannath, S.
    Jakubowiak, A.
    Lonial, S.
    Raje, N.
    Alsina, M.
    Ghobrial, I.
    Knight, R.
    Esseltine, D.
    Richardson, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345